Kiromic Biopharma, Inc. | Indemnification Agreements | Business Contracts

Indemnification Agreement effective as of February 14, 2022, by and between Kiromic BioPharma, Inc. and Daniel Clark (Filed With SEC on February 16, 2022)

Indemnification Agreement effective as of January 27, 2022 by and between Kiromic BioPharma, Inc. and Pietro Bersani (Filed With SEC on February 2, 2022)

Form of Director Indemnification Agreement, to be effective upon initial public offering, between Kiromic BioPharma, Inc. and all independent directors (Filed With SEC on June 26, 2020)

Kiromic Biopharma, Inc. (79) | Indemnification Agreements (3)